Literature DB >> 32151493

Pleiotropic roles of tankyrase/PARP proteins in the establishment and maintenance of human naïve pluripotency.

Ludovic Zimmerlin1, Elias T Zambidis2.   

Abstract

Tankyrase 1 (TNKS1; PARP-5a) and Tankyrase 2 (TNKS2; PARP-5b) are poly-ADP-ribosyl-polymerase (PARP)-domain-containing proteins that regulate the activities of a wide repertoire of target proteins via post-translational addition of poly-ADP-ribose polymers (PARylation). Although tankyrases were first identified as regulators of human telomere elongation, important and expansive roles of tankyrase activity have recently emerged in the development and maintenance of stem cell states. Herein, we summarize the current state of knowledge of the various tankyrase-mediated activities that may promote human naïve and 'extended' pluripotency'. We review the putative role of tankyrase and PARP inhibition in trophectoderm specification, telomere elongation, DNA repair and chromosomal segregation, metabolism, and PTEN-mediated apoptosis. Importantly, tankyrases possess PARP-independent activities that include regulation of MDC1-associated DNA repair by homologous recombination (HR) and autophagy/pexophagy, which is an essential mechanism of protein synthesis in the preimplantation embryo. Additionally, tankyrases auto-regulate themselves via auto-PARylation which augments their cellular protein levels and potentiates their non-PARP tankyrase functions. We propose that these non-PARP-related activities of tankyrase proteins may further independently affect both naïve and extended pluripotency via mechanisms that remain undetermined. We broadly outline a hypothetical framework for how inclusion of a tankyrase/PARP inhibitor in small molecule cocktails may stabilize and potentiate naïve and extended pluripotency via pleiotropic routes and mechanisms.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Human stem cell; Naive pluripotent stem cell; PARP; Pluripotency; Regenerative medicine; Tankyrase

Mesh:

Substances:

Year:  2020        PMID: 32151493      PMCID: PMC7171895          DOI: 10.1016/j.yexcr.2020.111935

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  134 in total

1.  Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells.

Authors:  Tobias A Beyer; Alexander Weiss; Yuliya Khomchuk; Kui Huang; Abiodun A Ogunjimi; Xaralabos Varelas; Jeffrey L Wrana
Journal:  Cell Rep       Date:  2013-12-12       Impact factor: 9.423

2.  Derivation of novel human ground state naive pluripotent stem cells.

Authors:  Ohad Gafni; Leehee Weinberger; Abed AlFatah Mansour; Yair S Manor; Elad Chomsky; Dalit Ben-Yosef; Yael Kalma; Sergey Viukov; Itay Maza; Asaf Zviran; Yoach Rais; Zohar Shipony; Zohar Mukamel; Vladislav Krupalnik; Mirie Zerbib; Shay Geula; Inbal Caspi; Dan Schneir; Tamar Shwartz; Shlomit Gilad; Daniela Amann-Zalcenstein; Sima Benjamin; Ido Amit; Amos Tanay; Rada Massarwa; Noa Novershtern; Jacob H Hanna
Journal:  Nature       Date:  2013-10-30       Impact factor: 49.962

3.  YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response.

Authors:  Luca Azzolin; Tito Panciera; Sandra Soligo; Elena Enzo; Silvio Bicciato; Sirio Dupont; Silvia Bresolin; Chiara Frasson; Giuseppe Basso; Vincenza Guzzardo; Ambrogio Fassina; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Cell       Date:  2014-06-26       Impact factor: 41.582

4.  Tankyrase-1 polymerization of poly(ADP-ribose) is required for spindle structure and function.

Authors:  Paul Chang; Margaret Coughlin; Timothy J Mitchison
Journal:  Nat Cell Biol       Date:  2005-11       Impact factor: 28.824

5.  Different telomere-length dynamics at the inner cell mass versus established embryonic stem (ES) cells.

Authors:  Elisa Varela; Ralph P Schneider; Sagrario Ortega; Maria A Blasco
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-24       Impact factor: 11.205

6.  Interaction between Poly(ADP-ribose) and NuMA contributes to mitotic spindle pole assembly.

Authors:  Paul Chang; Margaret Coughlin; Timothy J Mitchison
Journal:  Mol Biol Cell       Date:  2009-09-16       Impact factor: 4.138

7.  TRF1 is a stem cell marker and is essential for the generation of induced pluripotent stem cells.

Authors:  Ralph P Schneider; Ianire Garrobo; Miguel Foronda; Jose A Palacios; Rosa M Marión; Ignacio Flores; Sagrario Ortega; Maria A Blasco
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  Capacitation of human naïve pluripotent stem cells for multi-lineage differentiation.

Authors:  Maria Rostovskaya; Giuliano G Stirparo; Austin Smith
Journal:  Development       Date:  2019-04-03       Impact factor: 6.868

9.  Epiblast ground state is controlled by canonical Wnt/β-catenin signaling in the postimplantation mouse embryo and epiblast stem cells.

Authors:  Tomoyuki Sumi; Shinya Oki; Keiko Kitajima; Chikara Meno
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

10.  Epigenetic resetting of human pluripotency.

Authors:  Ge Guo; Ferdinand von Meyenn; Maria Rostovskaya; James Clarke; Sabine Dietmann; Duncan Baker; Anna Sahakyan; Samuel Myers; Paul Bertone; Wolf Reik; Kathrin Plath; Austin Smith
Journal:  Development       Date:  2017-08-01       Impact factor: 6.868

View more
  5 in total

1.  From development toward therapeutics, a collaborative effort on blood progenitors.

Authors:  Avik Choudhuri; Tianxiao Han; Leonard I Zon
Journal:  Stem Cell Reports       Date:  2021-06-10       Impact factor: 7.765

2.  Importance of WNT-dependent signaling for derivation and maintenance of primed pluripotent bovine embryonic stem cells†.

Authors:  Yao Xiao; Thiago F Amaral; Pablo J Ross; Delia A Soto; Kenneth E Diffenderfer; Aimee R Pankonin; Surawich Jeensuk; Paula Tríbulo; Peter J Hansen
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

Review 3.  Running the full human developmental clock in interspecies chimeras using alternative human stem cells with expanded embryonic potential.

Authors:  Justin Thomas; Ludovic Zimmerlin; Jeffrey S Huo; Michael Considine; Leslie Cope; Elias T Zambidis
Journal:  NPJ Regen Med       Date:  2021-05-17

4.  Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines.

Authors:  Line Mygland; Shoshy Alam Brinch; Martin Frank Strand; Petter Angell Olsen; Aleksandra Aizenshtadt; Kaja Lund; Nina Therese Solberg; Max Lycke; Tor Espen Thorvaldsen; Sandra Espada; Dorna Misaghian; Christian M Page; Oleg Agafonov; Ståle Nygård; Nai-Wen Chi; Eva Lin; Jenille Tan; Yihong Yu; Mike Costa; Stefan Krauss; Jo Waaler
Journal:  iScience       Date:  2021-07-01

5.  Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibitor: Part II.

Authors:  Ruben G G Leenders; Shoshy Alam Brinch; Sven T Sowa; Enya Amundsen-Isaksen; Albert Galera-Prat; Sudarshan Murthy; Sjoerd Aertssen; Johannes N Smits; Piotr Nieczypor; Eddy Damen; Anita Wegert; Marc Nazaré; Lari Lehtiö; Jo Waaler; Stefan Krauss
Journal:  J Med Chem       Date:  2021-12-08       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.